CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

Carmen Almódovar-Payá - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Carmen Almódovar-Payá

OPENALEX: A5057511334↗ORCID: 0000-0002-1952-1581↗

Affiliations

Organizations

Centro de Investigación Biomédica en Red de Salud Mentalauthorship · ES Fidmag Sisters Hospitallersauthorship · ES Instituto de Salud Carlos IIIauthorship · ES Universitat de Barcelonaauthorship · ES

Public evidence

3 connected articles

Clinical and cognitive outcomes in first-episode psychosis: focus on the interplay between cannabis use and genetic variability in endocannabinoid receptors.2024 · Europe PMC Genetic and Neurodevelopmental Markers in Schizophrenia-Spectrum Disorders: Analysis of the Combined Role of the <i>CNR1</i> Gene and Dermatoglyphics.2024 · Europe PMC Cannabis Use and Endocannabinoid Receptor Genes: A Pilot Study on Their Interaction on Brain Activity in First-Episode Psychosis.2023 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 09/09/2026.